NYSE - Delayed Quote
USD
AbbVie Inc. (ABBV)
291.31
+3.07
(+1.07%)
At close: November 6 at 4:01:45 PM EST
291.31
0.00
(0.00%)
After hours: November 6 at 6:26:03 PM EST
Trade AbbVie on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreNews headlines
Powered by Yahoo ScoutAbbVie enters the latest session with strong operating momentum, led by Skyrizi and Rinvoq, while expanding its pipeline through a potential $1.37 billion Nxera licensing deal. The main investor question is whether future growth can offset upcoming Inflation Reduction Act pricing pressure on Vraylar and maintain AbbVie’s premium valuation.[1][2][3]
